Difficulty: Medium
Average Score: 95%
Practice
Sue is diagnosed with congestive heart failure. What medication would you expect to administer to strengthen myocardial contractility?
Correct answer
B
Rationale
In the case of Sue, who has congestive heart failure, the medication that would be expected to administer to strengthen myocardial contractility is Digoxin (Option B). Digoxin is a cardiac glycoside that works by increasing the force of myocardial contraction, thereby improving heart function in patients with heart failure. It helps the heart pump more effectively and efficiently.
Option A, Nitroprusside, is a vasodilator used to reduce blood pressure in hypertensive emergencies. It does not directly impact myocardial contractility.
Option C, Nitroglycerine ointment, is primarily used to dilate blood vessels and reduce the workload on the heart. It is not specifically indicated for strengthening myocardial contractility.
Option D, Furosemide, is a loop diuretic that helps in reducing fluid overload by increasing urine output. While it can be beneficial in managing fluid retention in heart failure, it does not directly enhance myocardial contractility.
Educationally, understanding the rationale behind choosing Digoxin for Sue provides insight into the pharmacological management of congestive heart failure. It highlights the importance of selecting medications that target specific aspects of heart function to optimize patient outcomes. This knowledge is crucial for nurses caring for patients with heart failure to ensure safe and effective medication administration based on the underlying pathophysiology of the condition.
Option A, Nitroprusside, is a vasodilator used to reduce blood pressure in hypertensive emergencies. It does not directly impact myocardial contractility.
Option C, Nitroglycerine ointment, is primarily used to dilate blood vessels and reduce the workload on the heart. It is not specifically indicated for strengthening myocardial contractility.
Option D, Furosemide, is a loop diuretic that helps in reducing fluid overload by increasing urine output. While it can be beneficial in managing fluid retention in heart failure, it does not directly enhance myocardial contractility.
Educationally, understanding the rationale behind choosing Digoxin for Sue provides insight into the pharmacological management of congestive heart failure. It highlights the importance of selecting medications that target specific aspects of heart function to optimize patient outcomes. This knowledge is crucial for nurses caring for patients with heart failure to ensure safe and effective medication administration based on the underlying pathophysiology of the condition.